T he proximal tubule is a major site of salt and water reabsorption in the mammalian nephron, with up to 60% of the filtrate reabsorbed in this segment. 1, 2 Renal proximal tubule (RPT) function is under hormonal control, with angiotensin II stimulating sodium reabsorption via activation of apical Na ϩ /H ϩ exchanger and basolateral [Na ϩ ]/[K ϩ ]ATPase, and with dopamine inhibiting reabsorption by inhibiting these proteins. [3] [4] [5] The paracrine regulation of sodium reabsorption in the proximal tubule by the renin-angiotensin system occurs via several angiotensin receptor subtypes (AT 1 , AT 2 , and AT 4 ). [5] [6] [7] [8] The activation of AT 1 receptors by angiotensin II increases sodium transport, whereas the activation of AT 2 and AT 4 receptors decreases sodium reabsorption in this nephron segment. [5] [6] [7] [8] However, under physiological conditions, the major effect of angiotensin II on sodium transport is stimulatory, via AT 1 receptors. [5] [6] [7] [8] The dopaminergic system also exerts a paracrine regulatory role on renal sodium transport in the proximal tubule via several receptor subtypes. Dopamine receptors, pharmacologically grouped into D 1 -like (D 1 and D 5 ) and D 2 -like (D 2 , D 3 , and D 4 ) receptors, as with the angiotensin II receptors, are expressed in brush border and basolateral membranes of RPTs. In contrast to the stimulatory effect of angiotensin II on sodium transport in RPTs, the major consequence of the activation of dopamine receptors is an inhibition of sodium transport via D 1 -like and D 3 receptors. 3,4,9 -11 Previous studies have indicated that dopamine and angiotensin II subserve counteracting functions in the proximal tubule. Inhibition of RPT angiotensin II production or blockade of AT 1 receptors increases the natriuretic effect of the D 1 -like agonist fenoldopam. 9 D 1 -like and D 2 -like receptor agonists also antagonize the stimulatory effect of angiotensin II, acting via AT 1 receptors, on RPT luminal sodium transport. 12, 13 The renal vasoconstrictor effect of angiotensin II can also be antagonized by D 1 -like receptor agonists. 14 Alterations in the balance of the responsiveness of the proximal tubule to angiotensin II and dopamine have important impli-cations on net sodium reabsorption. Indeed, an altered interaction between angiotensin II and dopamine has been implicated in genetic hypertension. 4, 14 In a previous study, we showed that D 3 and AT 1 receptors co-localized in immortalized RPT cells from normotensive Wistar-Kyoto rats (WKY) and that D 3 dopamine receptors decreased AT 1 receptor protein expression in these cells. 15 We have found that these immortalized RPT cells have characteristics similar to freshly obtained RPT brush border membranes and RPTs, at least with regard to D 1 receptors and responses to G-protein stimulation. 16 -18 The present studies were designed to determine whether angiotensin II regulates AT 1 and D 3 receptor expression and whether the regulation is different in RPT cells from WKY and spontaneously hypertensive rats (SHR).
Methods

Cell Culture.
All studies have been approved by the Georgetown University Animal Care and Use Committee. Immortalized RPT cells obtained from 4-to 8 week-old WKY and SHR (Charles River Laboratory, Wilmington, Mass) were cultured at 37°C in 95% air/5% CO 2 atmosphere in Dulbecco modified Eagle's medium/F-12 culture media, as previously described. 17, 19 The cells (80% confluence) were extracted in ice-cold lysis buffer (PBS with 1% NP40, 0.5% sodium deoxycholate, 0.1% SDS, 1 mmol/L EDTA, 1 mmol/L EGTA, 1 mmol/L PMSF, 10 g/mL aprotinin, and 10 g/mL leupeptin), sonicated, kept on ice for 1 hour, and centrifuged at 16 000g for 30 minutes. The supernatants were stored at Ϫ70°C until use for immunoblotting and/or immunoprecipitation.
Immunoblotting
The antibodies are polyclonal purified antipeptides. The amino acid sequence for the immunogenic peptide (rabbit anti-human AT 1 receptor antibody) is QDDCPKAGRHC, amino acids 15-24 of the AT 1 receptor. The specificity of this antibody to the AT 1 receptor has been reported. 20 The amino acid sequence of the peptide for the rabbit anti-rat D 3 receptor antibody corresponds to the third intracellular loop of the D 3 receptor. 11, 21 We have reported the specificity of this D 3 receptor antibody. 11 Rat RPT cells were treated with vehicle (dH 2 O), angiotensin II, or an AT 1 receptor antagonist (losartan) at the indicated concentrations and times. 22 Immunoblotting was performed as previously reported, except that the transblots were probed with the D 3 (1:250) or the AT 1 receptor antibody (1:400). 11, 23, 24 The amount of protein transferred onto the membranes was determined by Ponceau-S staining and immunoblotting for ␣-actin.
Immunoprecipitation
RPT cells were incubated with vehicle or angiotensin II (10 Ϫ8 M) for 24 hours, as described above. The cells were lysed with ice-cold lysis buffer for 1 hour and centrifuged at 16 000g for 30 minutes. Equal amounts of lysates, except as indicated (300 g protein/mL supernatant for RPT cells from WKY and 900 g protein/mL supernatant for RPT cells from SHR) were incubated with affinity-purified anti-D 3 receptor antibody (1 g/mL) for 1 hour and G-protein agarose at 4°C for 12 hours. The immunoprecipitates were pelleted and washed 4 times with lysis buffer. The pellets were suspended in sample buffer, boiled for 10 minutes, and subjected to immunoblotting with the AT 1 receptor antibody. To determine the specificity of the bands, normal rabbit IgG (negative control) and AT 1 receptor antibody (positive control) were used as immunoprecipitants, instead of the D 3 receptor antibody. The density of the bands were quantified by densitometry, using Quantiscan as previously reported. 17, 19, 24 
Materials
Rabbit anti-rat D 3 and anti-human AT 1 receptor antibodies were purchased from Alpha Diagnostic International (D3R12A) and Santa Cruz Biotechnology Inc (sc-1173), respectively. Angiotensin II (H-17057002) was purchased from Peninsula Laboratory Inc. Losartan was a gift from Merck & Co (Philadelphia, Penn). Other chemicals for various buffers were of the highest purity available and purchased either from Sigma or GIBCO.
Statistical Analysis.
The data are expressed as meanϮSEM. Comparison within groups was made by ANOVA for repeated measures (or paired t test when only 2 groups were compared), and comparison among groups (or t test when only 2 groups were compared) was made by ANOVA with the Duncan test. A value of PϽ0.05 was considered significant.
Results
Specificity of Receptor Antibodies.
The bands for the AT 1 receptor (Ϸ45 kDa) and D 3 receptor (Ϸ45 kDa) were found in RPT cells, as previously reported. 11, 15 Another band of Ϸ40 kDa was noted for the D 3 receptor and probably represents a degradation product of the 45-kDa D 3 receptor. 21 The bands were specific because they were completely blocked when the antibodies were preadsorbed by the immunizing peptide ( Figures ; WKY: control, 36Ϯ3; angiotensin II, 24Ϯ3 DU; nϭ9 per group), but the reduction was greater in SHR (60Ϯ10%) than in WKY (32Ϯ9%) ( Figure 2C ). Basal D 3 receptor (45 KDa) levels were also lower in SHR compared with WKY, similar to our previous report. 11, 15 The specificity of angiotensin II as an AT 1 receptor agonist was also determined by studying the effect of the AT 1 receptor antagonist losartan. Consistent with the study shown in Figures 2A and 2B . Another band of Ϸ40 kDa, probably representing a degradation product of the D 3 receptor, was also noted. 21 The bands were no longer visualized when the antibody was preadsorbed with immunizing peptide (1:10 w/w). The effect of the D 2 -like receptor, by itself, on renal sodium transport is controversial; stimulation, no effect, and even inhibition have been reported. 4 The reason for the apparent discrepancies may be related to the different experimental conditions and the specific D 2 -like receptor involved. 3 27 which has a greater selectivity for D 3 than for D 2 or D 4 receptors also increased sodium excretion in salt-loaded but not salt-depleted WKY. These studies suggest that D 3 receptors, under certain circumstances, mediate a natriuresis, an effect that seems to be lost in SHR (C. Zeng, L.D. Asico, and P.A. Jose, unpublished data, 2002) . Whether the defective effect of D 3 receptors on sodium excretion in SHR is primary or secondary to interactions with other receptors is not known. However, preliminary studies from our laboratory indicate that the D 3 agonist, PD128907, increases D 1 receptor in RPT cells from WKY but has no effect in RPT cells from SHR. 15, 29 We have reported that mice lacking both D 3 receptor alleles developed systemic hypertension and a decreased ability to excrete a systemic sodium load. 10 In addition, renal renin activity and AT 1 receptor expression are much higher in the homozygous than in wild-type mice. 10, 15 Z1046, a dopaminergic agonist with a greater selectivity for D 3 and D 4 receptors over the other dopamine receptors, also increases sodium and water excretion in anesthetized WKY, but this effect is abrogated in SHR. 11, 30 These data suggest that a D 3 receptor defect may play a role in the pathogenesis of some forms of hypertension, most likely via an impaired renal excretory capacity for sodium or via an impaired inhibition/ interaction with renin-angiotensin system.
Duncan test). C, Differential effects of angiotensin (10
The current study shows that AT 1 receptor stimulation decreases D 3 receptor expression in RPT cells from both SHR and WKY, but the reduction in D 3 expression is greater in SHR than in WKY. The greater reduction in D 3 receptor expression in RPT cells caused by angiotensin II in SHR than in WKY may be caused by an increased activity of the AT 1 receptor in this rat strain. Indeed young SHR (5 to 7 weeks), the same age group as the rats in which the RPT cells are obtained for immortalization, RPT sodium transport is greater in SHR than in WKY. [31] [32] [33] Angiotensin II also increases renal proximal tubular sodium reabsorption to a greater extent in SHR than in WKY. 33 We also found that angiotensin II decreases AT 1 receptor in cells from WKY. There are a few studies on the effect of angiotensin II on AT 1 receptor expression in RPT cells. In rabbit RPT cells, a 16-hour incubation with angiotensin II dose-dependently increases AT 1 receptor expression, assessed by radioligand binding. 34 AT 1 receptor mRNAs in rat and rabbit RPT cells are also increased by angiotensin II (10 Ϫ8 M). 34, 35 However, the systemic administration of angiotensin II that increases systemic blood pressure does not alter total renal AT 1 receptor expression, determined by immunoblotting, but decreases AT 1 receptor expression (radioligand autoradiography) in glomeruli and inner stripe of the outer medulla. Three days after the infusion of angiotensin II, there is a tendency for a decrease in AT 1 expression in the whole kidney and in RPTs, but the changes are small and do not reach statistical significance, 36 results that could be taken to support our data. The differences in the results of these studies cannot be explained at this time.
In contrast to the inhibitory effect of angiotensin II on AT 1 expression in RPT cells from WKY, angiotensin II produces the opposite effect in RPT cells from SHR. The different effects of AT 1 agonist on D 3 receptor expression, and its own receptor, could be involved in the pathogenesis of hypertension in SHR. Decreased renal D 3 receptor expression and function have been reported in the Dahl salt-sensitive rat. 28 However, it is not known whether the D 3 receptor dysfunction in these rodent models of genetic hypertension is primary or secondary to a dysfunction of renal D 1 receptors. 4 An uncoupling of the D 1 receptor from its G-protein/effector complex in the kidney has been shown to be important in the pathogenesis of genetic hypertension. 4, 17 The mechanism for the decrease in D 3 receptor of the 45-kDa species caused by AT 1 receptors was not studied. However, the D 2 receptor, a member of the D 2 -like receptor, has been reported to decrease gene expression by translational and/or posttranslational protein modification. 21 It is possible that AT 1 receptors regulate D 3 receptor expression by similar mechanisms.
We now report that AT 1 and D 3 receptors can directly interact with each other. In the current studies, the basal level of AT 1 /D 3 co-immunoprecipitation is much lower in RPT cells from SHR than from WKY. AT 1 receptor stimulation results in a decreased interaction between AT 1 and D 3 receptors. The paucity of D 3 receptors on the RPT cell membranes could have been responsible for the decreased basal amount of D 3 and AT 1 receptor co-immunoprecipitation in SHR. Therefore, we tripled the amount of protein used for the immunoprecipitation studies in SHR. In a previous report, we found that doubling the amount of loaded protein from renal cortical membranes from SHR approximate D 3 expression in SHR to those observed in WKY. 11 Moreover, reversing the antibodies used for immunoprecipitation and immunoblotting, by using the AT 1 antibody for immunoprecipitation and the D 3 antibody for immunoblotting, gives similar results (data not shown). Therefore, it is unlikely that the low abundance of D 3 receptors in SHR could have caused the decreased amounts of D 3 and AT 1 receptor coimmunoprecipitation in this rat strain. We suggest that the strain differences could be caused by a differential expression in adaptor or interacting proteins. The ability of angiotensin II to decrease the amount of D 3 /AT 1 co-immunoprecipitation to the same degree in WKY and SHR suggests that the putative adaptor or interacting protein normally responds to angiotensin II. Further studies are needed to determine whether the decreased interaction between these 2 receptors is a direct or an indirect mechanism, possibly by the alteration of adaptor proteins. Thus, an adaptor protein for D 2 and D 3 receptors (protein 4.1N) has been recently identified that is important in their localization in plasma membranes. 37 Others have also shown that several G protein-coupled receptors interact directly with each other resulting in homo-or hetero-oligomerization. 21, 38 In summary, we have demonstrated that AT 1 receptors negatively regulate the expression of D 3 receptors in rat RPT cells. Furthermore, AT 1 and D 3 receptors interact in RPT cells, but this interaction is impaired in SHR.
Perspectives
The dopaminergic and renin-angiotensin systems are 2 important systems that regulate sodium excretion and blood pressure. 3-5 D 1 -like and D 2 -like dopamine receptors synergistically inhibit sodium reabsorption in RPTs. 4, 11, 30, 39 , The receptor subtypes mediating these synergistic effects are, most probably, D 1 and D 3 receptors because D 1 and D 3 receptors are the major dopamine receptors in the RPT cells. 4, 26 We have preliminary data showing an inhibition of Na ϩ -K ϩ ATPase activity by the stimulation of both D 1 and D 3 receptors (data not shown). In SHR, the synergistic interaction between D 1 -like and D 2 -like receptors is impaired. 11 D 3 receptor expression (45 kDa), in renal brush border membranes and RPT cells, is lower in rodent hypertensive models relative to normotensive controls. 11, 28 Despite similar abundance of D 1 receptors in RPTs in human essential and rodent genetic hypertension, 4 D 1 receptor function is impaired because of increased G protein-coupled receptor kinase (GRK) 4 and decreased phospholipase 2A (PP2A) activities. 18, 40, 41 It is possible that GRK 4 and PP2A have a similar effect on D 3 receptors, causing the decrease in D 3 receptor expression and function. Activation of D 1 receptor or D 3 receptor decreases AT 1 receptor expression in RPT cells from WKY, and those effects are impaired in SHR. 2, 15 AT 1 receptor activity is higher in SHR [5] [6] [7] 33 ; however, it has not been determined whether the increased AT 1 receptor expression or function is primary or secondary to derangements of other systems. We hypothesize the increased AT 1 receptor activity in SHR is secondary to an impaired dopaminergic system, related to GRK4, D 1 , and D 3 receptors. This hypothesis will be tested in future studies.
